ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 589,82
-0,56%
Dow Jones
40 211,72
0,53%
DAX
18 501,92
-0,53%
Brent Oil
83,625
-0,85%
Bitcoin
62 800,50
-3,16%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intellia Therapeutics Inc (NTLA)

  7. Intellia Therapeutics Inc (NTLA) Actualités

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateHeureSourceTitreSymboleSociété
08/03/201713h30GlobeNewswire Inc.Intellia Therapeutics Demonstrates Pioneering CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery T...NASDAQ:NTLAIntellia Therapeutics Inc
07/03/201721h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
01/03/201713h10GlobeNewswire Inc.Intellia Therapeutics to Present at March Investor Healthcare ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
16/02/201700h41GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Address Patent Interference ProceedingsNASDAQ:NTLAIntellia Therapeutics Inc
15/02/201722h58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
15/02/201721h19GlobeNewswire Inc.CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent In...NASDAQ:NTLAIntellia Therapeutics Inc
14/02/201717h29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
09/02/201722h39Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTLAIntellia Therapeutics Inc
07/02/201719h47Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:NTLAIntellia Therapeutics Inc
01/02/201722h05GlobeNewswire Inc.Intellia Therapeutics to Present at Leerink Partners 6th Annual Global Healthcare ConferenceNASDAQ:NTLAIntellia Therapeutics Inc
11/01/201722h39GlobeNewswire Inc.Intellia Therapeutics Joins Genomics England’s Industry ConsortiumNASDAQ:NTLAIntellia Therapeutics Inc
20/12/201622h48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
16/12/201614h00GlobeNewswire Inc.CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundationa...NASDAQ:NTLAIntellia Therapeutics Inc
13/12/201615h20GlobeNewswire Inc.Intellia Therapeutics Names Graeme Bell Chief Financial OfficerNASDAQ:NTLAIntellia Therapeutics Inc
01/12/201622h05GlobeNewswire Inc.Intellia Therapeutics Opens New Headquarters as Company Continues to Advance CRISPR/Cas9 Platform and PipelineNASDAQ:NTLAIntellia Therapeutics Inc
01/11/201621h29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
01/11/201621h05GlobeNewswire Inc.Intellia Therapeutics Reports Financial Results for Third Quarter 2016NASDAQ:NTLAIntellia Therapeutics Inc
31/10/201612h00GlobeNewswire Inc.Intellia Therapeutics to Present at November Investor Healthcare ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
14/10/201613h00GlobeNewswire Inc.Intellia Therapeutics to Present Data at the European Society of Gene & Cell Therapy CongressNASDAQ:NTLAIntellia Therapeutics Inc
05/10/201613h00GlobeNewswire Inc.Intellia Therapeutics to Present at Jefferies Gene Editing/Therapy SummitNASDAQ:NTLAIntellia Therapeutics Inc
01/09/201613h00GlobeNewswire Inc.Intellia Therapeutics to Present at September Investor Healthcare ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
19/08/201603h37GlobeNewswire Inc.Intellia Therapeutics’ Preclinical Data Show Continued Progress in In Vivo Gene Editing With Systemic Lipid Nanoparticle De...NASDAQ:NTLAIntellia Therapeutics Inc
10/08/201622h05GlobeNewswire Inc.Intellia Therapeutics to Present at 2016 Wedbush PacGrow Healthcare ConferenceNASDAQ:NTLAIntellia Therapeutics Inc
04/08/201622h10GlobeNewswire Inc.Intellia Therapeutics Reports Financial Results for Second Quarter 2016NASDAQ:NTLAIntellia Therapeutics Inc
03/06/201622h03GlobeNewswire Inc.Intellia Therapeutics to Present at the Jefferies 2016 Healthcare Conference and the International BIO ConventionNASDAQ:NTLAIntellia Therapeutics Inc
20/05/201622h07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NTLAIntellia Therapeutics Inc
11/05/201622h05GlobeNewswire Inc.Intellia Therapeutics Announces Closing of Initial Public OfferingNASDAQ:NTLAIntellia Therapeutics Inc
11/05/201616h00GlobeNewswire Inc.Intellia Therapeutics, Inc. (Nasdaq: NTLA) to Ring The Nasdaq Stock Market Opening BellNASDAQ:NTLAIntellia Therapeutics Inc
06/05/201601h02GlobeNewswire Inc.Intellia Therapeutics Announces Pricing of Initial Public OfferingNASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA

Dernières Valeurs Consultées

EU
RNO
Renault
EU
VK
Vallourec
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
EU
EN
Bouygues
NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
EU
DG
Vinci
EU
LR
Legrand
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés